{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T10:30:12Z","timestamp":1723717812970},"reference-count":299,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1157\/13101982","type":"journal-article","created":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T17:35:58Z","timestamp":1180632958000},"page":"294-314","source":"Crossref","is-referenced-by-count":3,"title":["Errores frecuentes en el manejo del paciente grave con enfermedad inflamatoria intestinal"],"prefix":"10.1016","volume":"30","author":[{"given":"Javier P.","family":"Gisbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13101982_bib1","series-title":"Los or\u00edgenes de las enfermedades humanas","author":"McKeown","year":"2006"},{"key":"10.1157\/13101982_bib2","series-title":"N\u00e9mesis m\u00e9dica","author":"Ilich","year":"1978"},{"key":"10.1157\/13101982_bib3","series-title":"La voluntad de vivir","author":"Camps","year":"2005"},{"key":"10.1157\/13101982_bib4","series-title":"Infections and inequalities","author":"Farmer","year":"1999"},{"key":"10.1157\/13101982_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/bmj.320.7237.768","article-title":"Human error: models and management","volume":"320","author":"Reason","year":"2000","journal-title":"BMJ"},{"key":"10.1157\/13101982_bib6","series-title":"To err is human: building a safer health system","author":"Kohn","year":"1999"},{"issue":"Suppl 2","key":"10.1157\/13101982_bib7","first-page":"28","article-title":"Beyond the organisational accident: the need for \u00aberror wisdom\u00bb on the frontline","volume":"13","author":"Reason","year":"2004","journal-title":"Qual Saf Health Care"},{"key":"10.1157\/13101982_bib8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMsb051157","article-title":"Accidental deaths, saved lives, and improved quality","volume":"353","author":"Brennan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13101982_bib9","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMsa054479","article-title":"Claims, errors, and compensation payments in medical malpractice litigation","volume":"354","author":"Studdert","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1157\/13101982_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bmj.320.7237.725","article-title":"Safe health care: are we up to it?","volume":"320","author":"Leape","year":"2000","journal-title":"Bmj"},{"key":"10.1157\/13101982_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/bmj.320.7237.781","article-title":"On error management: lessons from aviation","volume":"320","author":"Helmreich","year":"2000","journal-title":"Bmj"},{"key":"10.1157\/13101982_bib12","first-page":"56","article-title":"Safety in the operating theatre (II): human error and organisational failure","volume":"14","author":"Reason","year":"2005","journal-title":"Qual Saf Health Care"},{"issue":"Suppl 4","key":"10.1157\/13101982_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2036.16.s4.2.x","article-title":"Review article: medical treatment of severe ulcerative colitis","volume":"16","author":"Daperno","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"241","author":"Truelove","year":"1955","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1157\/13101982_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","article-title":"Classification of inflammatory bowel disease","volume":"170","author":"Lennard-Jones","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"10.1157\/13101982_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0950-3528(97)90058-0","article-title":"Management of the first presentation of severe acute colitis","volume":"11","author":"Leiper","year":"1997","journal-title":"Baillieres Clin Gastroenterol"},{"key":"10.1157\/13101982_bib17","first-page":"243","article-title":"Infectious diseases mimicking inflammatory bowel disease","volume":"48","author":"Tedesco","year":"1982","journal-title":"Am Surg"},{"key":"10.1157\/13101982_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-7125(16)30584-3","article-title":"Infectious causes of diarrhea in the differential diagnosis of inflammatory bowel disease","volume":"74","author":"Farmer","year":"1990","journal-title":"Med Clin North Am"},{"key":"10.1157\/13101982_bib19","first-page":"8","article-title":"Infecciones en la enfermedad inflamatoria intestinal","volume":"5","author":"Domenech","year":"2006","journal-title":"Enfermedad Inflamatoria Intestinal al D\u00eda"},{"key":"10.1157\/13101982_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00365528309181560","article-title":"Occurrence of Clostridium difficile toxin in inflammatory bowel disease","volume":"18","author":"Rolny","year":"1983","journal-title":"Scand J Gastroenterol"},{"key":"10.1157\/13101982_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.24.8.713","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"24","author":"Greenfield","year":"1983","journal-title":"Gut"},{"key":"10.1157\/13101982_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00004836-199206000-00008","article-title":"Microbic superinfection in relapse of inflammatory bowel disease","volume":"14","author":"Weber","year":"1992","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00004836-199301000-00008","article-title":"Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile","volume":"16","author":"Kochhar","year":"1993","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00054725-200205000-00009","article-title":"Role of infections in the manifestation or reactivation of inflammatory bowel diseases","volume":"8","author":"Stallmach","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1157\/13101982_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.meg.0000131040.38607.09","article-title":"Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool","volume":"16","author":"Mylonaki","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0889-8553(01)00012-7","article-title":"Inflammatory bowel disease. Medical therapy of specific clinical presentations","volume":"31","author":"Banerjee","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1157\/13101982_bib27","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0889-8553(03)00095-5","article-title":"Inflammatory bowel disease emergencies","volume":"32","author":"Cheung","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1157\/13101982_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.gtc.2004.02.011","article-title":"Management of refractory inflammatory bowel disease","volume":"33","author":"Solem","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1157\/13101982_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.gtc.2004.02.005","article-title":"Medical management of severe ulcerative colitis","volume":"33","author":"Chang","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"issue":"Suppl 5","key":"10.1157\/13101982_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.2004.043372","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"53","author":"Carter","year":"2004","journal-title":"Gut"},{"key":"10.1157\/13101982_bib31","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","article-title":"Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee","volume":"99","author":"Kornbluth","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/bmj.333.7563.340","article-title":"Ulcerative colitis: diagnosis and management","volume":"333","author":"Collins","year":"2006","journal-title":"Bmj"},{"key":"10.1157\/13101982_bib33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.mcg.0000139057.05297.d6","article-title":"The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease","volume":"38","author":"Meyer","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib34","first-page":"168","article-title":"Estudio prospectivo sobre la incidencia de infecci\u00f3n gastrointestinal por enteropat\u00f3genos en pacientes con enfermdad inflamatoria intestinal en brote de actividad","volume":"28","author":"Navarro","year":"2006","journal-title":"Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-111-8-641","article-title":"6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity","volume":"111","author":"Present","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1157\/13101982_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1157\/13072012","article-title":"GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease","volume":"28","author":"Dom\u00e9nech","year":"2005","journal-title":"Gastroenterol Hepatol"},{"issue":"Suppl 4","key":"10.1157\/13101982_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2036.2004.02056.x","article-title":"Review article: the management of mild to severe acute ulcerative colitis","volume":"20","author":"Travis","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(80)90940-X","article-title":"Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease?","volume":"1","author":"Bolton","year":"1980","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0016-5085(81)90127-X","article-title":"Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease","volume":"80","author":"Trnka","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0016-5085(81)90128-1","article-title":"Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease","volume":"80","author":"Meyers","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00004836-198510000-00003","article-title":"Lack of relationship between Clostridium difficile toxin and inflammatory bowel disease in children","volume":"7","author":"Hyams","year":"1985","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005176-199107000-00007","article-title":"Clostridium difficile in inflammatory bowel disease relapse","volume":"13","author":"Gryboski","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1157\/13101982_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-662-06272-2_6","article-title":"Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis","volume":"250","author":"Farrell","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1157\/13101982_bib44","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/gut.23.5.410","article-title":"Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease","volume":"23","author":"Keighley","year":"1982","journal-title":"Gut"},{"key":"10.1157\/13101982_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(80)90939-3","article-title":"Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease","volume":"1","author":"LaMont","year":"1980","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib46","first-page":"85","article-title":"Clostridium difficile colitis","volume":"29","author":"Trnka","year":"1984","journal-title":"Adv Intern Med"},{"key":"10.1157\/13101982_bib47","series-title":"Enfermedad inflamatoria intestinal","first-page":"303","article-title":"Diagn\u00f3stico por la imagen de la enfermedad inflamatoria intestinal","author":"Dom\u00e9nech","year":"2002"},{"issue":"Suppl 1","key":"10.1157\/13101982_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.2005.081950a","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut"},{"key":"10.1157\/13101982_bib49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-8553(05)70062-5","article-title":"Imaging modalities in inflammatory bowel disease","volume":"28","author":"Scotiniotis","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1157\/13101982_bib50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000201287","article-title":"Plain X-ray films and air enema films reflect severe mucosal inflammation in acute ulcerative colitis","volume":"56","author":"Almer","year":"1995","journal-title":"Digesti\u00f3n"},{"key":"10.1157\/13101982_bib51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00004836-198704000-00010","article-title":"Early recognition of toxic megacolon","volume":"9","author":"Caprilli","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib52","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gut.32.12.1535","article-title":"Small bowel gas in severe ulcerative colitis","volume":"32","author":"Chew","year":"1991","journal-title":"Gut"},{"key":"10.1157\/13101982_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0899-7071(03)00204-3","article-title":"CT evaluation of gastrointestinal tract perforation","volume":"28","author":"Yeung","year":"2004","journal-title":"Clin Imaging"},{"key":"10.1157\/13101982_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0016-5085(76)80430-1","article-title":"More on colonoscopy in inflammatory bowel disease [letter]","volume":"70","author":"Marshak","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib55","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0025-7125(16)30214-0","article-title":"Toxic megacolon","volume":"77","author":"Present","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1157\/13101982_bib56","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0016-5107(98)70062-8","article-title":"American Society for Gastrointestinal Endoscopy","volume":"48","year":"1998","journal-title":"Gastrointest Endosc"},{"key":"10.1157\/13101982_bib57","first-page":"415","article-title":"Actitud ante un megacolon t\u00f3xico","volume":"95","author":"Gonz\u00e1lez Lara","year":"2003","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1157\/13101982_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/00365521.1975.12096987","article-title":"Toxic megacolon in ulcerative colitis","volume":"10","author":"Koudahl","year":"1975","journal-title":"Scand J Gastroenterol"},{"key":"10.1157\/13101982_bib59","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.2003.07696.x","article-title":"A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management","volume":"98","author":"Gan","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1157\/13101982_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2036.17.s2.18.x","article-title":"Review article: medical treatment of severe ulcerative colitis","volume":"17","author":"Rizzello","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-3565(04)00441-0","article-title":"Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice","volume":"3","author":"Fefferman","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib62","first-page":"187","article-title":"Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making","volume":"86","author":"Alemayehu","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib63","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1055\/s-1999-126","article-title":"Appropriateness of colonoscopy: inflammatory bowel disease","volume":"31","author":"Froehlich","year":"1999","journal-title":"Endoscopy"},{"key":"10.1157\/13101982_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0889-8553(01)00008-5","article-title":"Endoscopy in inflammatory bowel disease","volume":"31","author":"Lee","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1157\/13101982_bib65","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.gie.2006.02.005","article-title":"ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease","volume":"63","author":"Leighton","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1157\/13101982_bib66","first-page":"653","article-title":"Assessment of intestinal inflammatory disease activity using gammagraphy with 99mTc-HMPAO-labelled leukocytes","volume":"89","author":"Gomollon","year":"1997","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1157\/13101982_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9610(02)00879-6","article-title":"Acute surgical emergencies in inflammatory bowel disease","volume":"184","author":"Berg","year":"2002","journal-title":"Am J Surg"},{"key":"10.1157\/13101982_bib68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00535-003-1317-2","article-title":"The clinical characteristics and outcome of intra-abdominal abscess in Crohn\u2019s disease","volume":"39","author":"Yamaguchi","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1157\/13101982_bib69","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0016-5085(82)80139-X","article-title":"Incidence and microbiology of abdominal and pelvic abscess in Crohn\u2019s disease","volume":"83","author":"Keighley","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib70","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2214\/ajr.150.5.1043","article-title":"Percutaneous drainage of abscesses in patients with Crohn disease","volume":"150","author":"Lambiase","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"10.1157\/13101982_bib71","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01889070","article-title":"Percutaneous drainage of abscesses in patients with Crohn\u2019s disease","volume":"13","author":"Doemeny","year":"1988","journal-title":"Gastrointest Radiol"},{"key":"10.1157\/13101982_bib72","first-page":"678","article-title":"Intra-abdominal abscesses in Crohn\u2019s disease","volume":"56","author":"Cybulsky","year":"1990","journal-title":"Am Surg"},{"key":"10.1157\/13101982_bib73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00000658-199101000-00006","article-title":"Intra-abdominal abscess in regional enteritis","volume":"213","author":"Ribeiro","year":"1991","journal-title":"Ann Surg"},{"key":"10.1157\/13101982_bib74","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF02365438","article-title":"Intestinal and extraintestinal complications of Crohn\u2019s disease: predictors and cumulative probability of complications","volume":"29","author":"Maeda","year":"1994","journal-title":"J Gastroenterol"},{"key":"10.1157\/13101982_bib75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2168.1998.00575.x","article-title":"Intra-abdominal and pelvic abscess in Crohn\u2019s disea se: results of noninvasive and surgical management","volume":"85","author":"Jawhari","year":"1998","journal-title":"Br J Surg"},{"key":"10.1157\/13101982_bib76","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2036.2001.00963.x","article-title":"Review article: the management of severe Crohn\u2019s disease","volume":"15","author":"Parkes","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 4","key":"10.1157\/13101982_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2036.16.s4.6.x","article-title":"Review article: the management of refractory Crohn\u2019s disease","volume":"16","author":"Rizzello","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib78","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(02)07284-7","article-title":"Crohn\u2019s disease","volume":"359","author":"Shanahan","year":"2002","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1157\/13101982_bib79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2036.17.s2.23.x","article-title":"Review article: medical treatment of moderate to severe Crohn\u2019 s disease","volume":"17","author":"Scribano","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib80","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.dld.2005.12.001","article-title":"Nonsurgical treatment of abdominal or pelvic abscess in consecutive patients with Crohn\u2019s disease","volume":"38","author":"Lee","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib81","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004836-200105000-00010","article-title":"Abscesses in Crohn\u2019s disease: outcome of medical versus surgical treatment","volume":"32","author":"Garc\u00eda","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000083867","article-title":"Severe and steroid-resistant Crohn\u2019s disease","volume":"71","author":"Michetti","year":"2005","journal-title":"Digestion"},{"key":"10.1157\/13101982_bib83","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.dld.2006.04.018","article-title":"Abscess and Crohn\u2019s disease. Early surgery or percutaneous drainage? A British view","volume":"38","author":"Mortensen","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archsurg.1986.01400020027001","article-title":"Operative vs percutaneous drainage of intra-abdominal abscesses. Comparison of morbidity and mortality","volume":"121","author":"Olak","year":"1986","journal-title":"Arch Surg"},{"key":"10.1157\/13101982_bib85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1148\/radiology.163.1.3823434","article-title":"Abscesses in Crohn disease: percutaneous drainage","volume":"163","author":"Casola","year":"1987","journal-title":"Radiology"},{"key":"10.1157\/13101982_bib86","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2214\/ajr.148.5.859","article-title":"Percutaneous abscess drainage in Crohn\u2019s disease","volume":"148","author":"Safrit","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"10.1157\/13101982_bib87","first-page":"5","article-title":"Management of intra-abdominal abscesses in Crohn\u2019s disease","volume":"78","author":"Ayuk","year":"1996","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1157\/13101982_bib88","first-page":"275","article-title":"Percutaneous drainage of intra-abdominal abscesses in Crohn\u2019s disease: short and long-term outcome","volume":"92","author":"Sahai","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib89","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiol.2223010554","article-title":"Percutaneous abscess drainage in Crohn disease: technical success and short\u2013 and long-term outcomes during 14 years","volume":"222","author":"Gervais","year":"2002","journal-title":"Radiology"},{"issue":"Suppl 1","key":"10.1157\/13101982_bib90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/gut.2005.081950b","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: current management","volume":"55","author":"Travis","year":"2006","journal-title":"Gut"},{"key":"10.1157\/13101982_bib91","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10151-006-0260-7","article-title":"CT-guided percutaneous pelvic abscess drainage in Crohn\u2019s disease","volume":"10","author":"Golfieri","year":"2006","journal-title":"Tech Coloproctol"},{"key":"10.1157\/13101982_bib92","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.dld.2006.04.006","article-title":"Abscess in Crohn\u2019s disease. The knife may not be necessary (an American view)","volume":"38","author":"Nath","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib93","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1111\/j.1572-0241.2006.00757.x","article-title":"Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn\u2019s disease","volume":"101","author":"Gutierrez","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib94","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0399-8320(05)82174-8","article-title":"Intestinal perforation in Crohn\u2019s disease. Factors predictive of surgical resection","volume":"29","author":"Brihier","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1157\/13101982_bib95","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0016-5085(79)90385-8","article-title":"National Cooperative Crohn\u2019s Disease Study: results of drug treatment","volume":"77","author":"Summers","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib96","first-page":"1450","article-title":"The safety of corticosteroid therapy in Crohn\u2019s disease with an abdominal mass","volume":"86","author":"Felder","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib97","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/BF02236563","article-title":"Risk factors for intra-abdominal sepsis after surgery in Crohn\u2019s disease","volume":"43","author":"Yamamoto","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1157\/13101982_bib98","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00054725-200209000-00001","article-title":"Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications","volume":"8","author":"Mahadevan","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1157\/13101982_bib99","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00000658-200202000-00008","article-title":"Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis","volume":"235","author":"Heuschen","year":"2002","journal-title":"Ann Surg"},{"key":"10.1157\/13101982_bib100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0016-5085(03)00883-7","article-title":"Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients","volume":"125","author":"Aberra","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib101","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S1542-3565(05)00759-7","article-title":"Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn\u2019s disease","volume":"3","author":"Agrawal","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib102","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0016-5085(75)80270-8","article-title":"Clinical patterns in Crohn\u2019s disease: a statistical study of 615 cases","volume":"68","author":"Farmer","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib103","first-page":"1121","article-title":"Spanish Epidemiological and Economic Study Group on Crohn\u2019s disease","volume":"11","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib104","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0210-5705(02)70313-0","article-title":"Treatment of stenosis due to Crohn\u2019s disease","volume":"25","author":"Gisbert","year":"2002","journal-title":"Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00054725-200305000-00011","article-title":"Ten common errors in the management of inflammatory bowel disease","volume":"9","author":"Sachar","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"10.1157\/13101982_bib106","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(97)10475-5","article-title":"Toxic megacolon","volume":"351","author":"Sheth","year":"1998","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0016-5085(19)33962-9","article-title":"An experience with ulcerative colitis: toxic dilatation in 55 cases","volume":"57","author":"Jalan","year":"1969","journal-title":"Gastroenterology"},{"issue":"Suppl A","key":"10.1157\/13101982_bib108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1157\/13101982_bib109","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1157\/13101982_bib110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00054725-200405000-00011","article-title":"The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research","volume":"10","author":"Hommes","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1157\/13101982_bib111","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.3748\/wjg.v12.i30.4813","article-title":"Cytomegalovirus and inflammatory bowel disease: is there a link?","volume":"12","author":"Criscuoli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1157\/13101982_bib112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02235178","article-title":"Cytomegaloviral enterocolitis: clinical associations and outcome","volume":"42","author":"Kaufman","year":"1999","journal-title":"Dis Colon Rectum"},{"key":"10.1157\/13101982_bib113","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/j.1572-0241.2001.03949.x","article-title":"Outcome of cytomegalovirus infections in patients with inflammatory bowel disease","volume":"96","author":"Papadakis","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib114","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.dld.2004.08.003","article-title":"Hunting for the owl\u2019s eye in acute severe colitis: the role of cytomegalovirus","volume":"36","author":"Loftus","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib115","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1572-0241.1999.01013.x","article-title":"Cytomegalovirus infection in patients with inflammatory bowel disease","volume":"94","author":"Vega","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib116","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0025-7753(00)71244-9","article-title":"Infecci\u00f3n por citomegalovirus en pacientes con colitis ulcerosa tratados con colectom\u00eda","volume":"114","author":"Alcal\u00e1","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13101982_bib117","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1572-0241.2001.03620.x","article-title":"Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn\u2019s colitis","volume":"96","author":"Cottone","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib118","first-page":"S59","article-title":"Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment","volume":"46","author":"Wada","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1157\/13101982_bib119","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000478-200403000-00009","article-title":"Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study","volume":"28","author":"Kambham","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1157\/13101982_bib120","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s10350-003-0117-3","article-title":"Prevalence of cytomegalovirus infection in inflammatory bowel disease patients","volume":"47","author":"Takahashi","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1157\/13101982_bib121","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.dld.2004.05.013","article-title":"Severe acute colitis associated with CMV: a prevalence study","volume":"36","author":"Criscuoli","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib122","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/pgmj.2003.007385","article-title":"Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature","volume":"80","author":"Hamlin","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1157\/13101982_bib123","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archinte.1990.00040031749028","article-title":"Acute ulcerative proctocolitis associated with primary cytomegalovirus infection","volume":"150","author":"Diepersloot","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1157\/13101982_bib124","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/BF01970971","article-title":"Primary cytomegalovirus infection associated with the onset of ulcerative colitis","volume":"12","author":"Lortholary","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13101982_bib125","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/BF01299914","article-title":"Cytomegalovirus infection associated with onset of inflammatory bowel disease","volume":"38","author":"Orvar","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1157\/13101982_bib126","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00004836-199412000-00010","article-title":"Cytomegalovirus as an exacerbating factor in ulcerative colitis","volume":"19","author":"Loftus","year":"1994","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib127","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1572-0241.2001.03672.x","article-title":"Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient","volume":"96","author":"Pfau","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(79)90176-4","article-title":"Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease","volume":"2","author":"Swarbrick","year":"1979","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib129","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/gut.27.12.1419","article-title":"Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy","volume":"27","author":"Eyre-Brook","year":"1986","journal-title":"Gut"},{"key":"10.1157\/13101982_bib130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0016-5085(77)80021-8","article-title":"Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection","volume":"72","author":"Cooper","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib131","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jmv.1890380306","article-title":"Detection of herpesvirus DNA in the large in-testine of patients with ulcerative colitis and Crohn\u2019s disease using the nested polymerase chain reaction","volume":"38","author":"Wakefield","year":"1992","journal-title":"J Med Virol"},{"key":"10.1157\/13101982_bib132","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1067\/mge.2001.114955","article-title":"Cytomegalovirus infection in a patient with ulcera tive colitis: colonoscopic findings","volume":"53","author":"Nishimoto","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1157\/13101982_bib133","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/JCM.30.8.1937-1941.1992","article-title":"Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections","volume":"30","author":"Brytting","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13101982_bib134","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00007890-199504000-00010","article-title":"Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation","volume":"59","author":"Schmidt","year":"1995","journal-title":"Transplantation"},{"key":"10.1157\/13101982_bib135","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/JCM.36.2.526-530.1998","article-title":"Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation","volume":"36","author":"M\u00e9ndez","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13101982_bib136","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI200418975","article-title":"Enhancement of MEK\/ERK signaling promotes glucocorticoid resistance in CD4+ T cells","volume":"1 13","author":"Tsitoura","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1157\/13101982_bib137","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0210-5705(05)71528-4","article-title":"Ciclosporina en el brote grave de colitis ulcerosa","volume":"28","author":"Nos","year":"2005","journal-title":"Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib138","series-title":"Enfermedad inflamatoria intestinal","first-page":"351","article-title":"Nutrici\u00f3n en la enfermedad inflamatoria intestinal","author":"Fern\u00e1ndez-Ba\u00f1ares","year":"2002"},{"key":"10.1157\/13101982_bib139","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bpg.2006.03.001","article-title":"Nutrition in inflammatory bowel disease","volume":"20","author":"O\u2019Sullivan","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1157\/13101982_bib140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(80)90913-0","article-title":"Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis","volume":"79","author":"Dickinson","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib141","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/gut.27.5.481","article-title":"Controlled trial of bowel rest in the treatment of severe acute colitis","volume":"27","author":"McIntyre","year":"1986","journal-title":"Gut"},{"key":"10.1157\/13101982_bib142","first-page":"227","article-title":"Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis","volume":"88","author":"Gonz\u00e1lez-Huix","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib143","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2036.2003.01482.x","article-title":"Review article: nutrition and adult inflammatory bowel disease","volume":"17","author":"Goh","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 4","key":"10.1157\/13101982_bib144","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2004.02050.x","article-title":"Review article: the role of nutrition in the treatment of inflammatory bowel disease","volume":"20","author":"Gassull","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib145","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/BF02051922","article-title":"The starved colon: diminished mucosal nutrition, diminished absorption, and colitis","volume":"33","author":"Roediger","year":"1990","journal-title":"Dis Colon Rectum"},{"key":"10.1157\/13101982_bib146","first-page":"892","article-title":"Surgical measures as supplements to the management of idiopathic ulcerative colitis; cancer, cirrhosis, and arthritis as frequent complications","volume":"32","author":"Dennis","year":"1952","journal-title":"Surgery"},{"key":"10.1157\/13101982_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.5.1.1","article-title":"The course and prognosis of ulcerative colitis. Complications","volume":"5","author":"Edwards","year":"1964","journal-title":"Gut"},{"key":"10.1157\/13101982_bib148","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archinte.1966.03870090061010","article-title":"Venous thrombosis occurring in non-specific ulcerative colitis","volume":"117","author":"Graef","year":"1966","journal-title":"Arch Intern Med"},{"issue":"Suppl","key":"10.1157\/13101982_bib149","first-page":"819","article-title":"Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases","volume":"54","author":"loan","year":"1968","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0025-6196(12)65200-8","article-title":"Vascular complications of inflammatory bowel disease","volume":"61","author":"Talbot","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"10.1157\/13101982_bib151","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.34.2.247","article-title":"Thromboembolism in inflammatory bowel disease: role of platelets","volume":"34","author":"Webberley","year":"1993","journal-title":"Gut"},{"key":"10.1157\/13101982_bib152","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/qjmed\/90.3.183","article-title":"Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden","volume":"90","author":"Jackson","year":"1997","journal-title":"Qjm"},{"key":"10.1157\/13101982_bib153","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000051389","article-title":"Role of thrombotic vascular risk factors in inflammatory bowel disease","volume":"18","author":"Koutroubakis","year":"2000","journal-title":"Dig Dis"},{"key":"10.1157\/13101982_bib154","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0037-1615600","article-title":"The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study","volume":"85","author":"Bernstein","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1157\/13101982_bib155","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/j.1572-0241.2004.40923.x","article-title":"Thromboembolism: an important manifestation of inflammatory bowel disease","volume":"99","author":"Quera","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib156","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1572-0241.2003.04026.x","article-title":"Venous thromboembolism in inflammatory bowel disease","volume":"99","author":"Solem","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib157","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gut.2003.025411","article-title":"Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?","volume":"53","author":"Miehsler","year":"2004","journal-title":"Gut"},{"key":"10.1157\/13101982_bib158","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1361.058","article-title":"Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications","volume":"1051","author":"Twig","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1157\/13101982_bib159","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00042737-200507000-00001","article-title":"Venous thrombosis in inflammatory bowel disease","volume":"17","author":"Srirajaskanthan","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib160","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1542-3565(05)00154-0","article-title":"Thrombosis and inflammatory bowel disease","volume":"3","author":"Irving","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib161","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/gut.38.5.733","article-title":"Thrombotic vascular risk factors in inflammatory bowel disease","volume":"38","author":"Hudson","year":"1996","journal-title":"Gut"},{"key":"10.1157\/13101982_bib162","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1572-0241.2005.42029.x","article-title":"Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia","volume":"100","author":"Spina","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib163","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1572-0241.1999.00937.x","article-title":"Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease","volume":"94","author":"Novacek","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib164","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1538-7836.2003.t01-6-00326.x","article-title":"Spontaneous venous thrombosis in inflammatory bowel disease: relevance of factor V Leiden and the prothrombin gene mutation","volume":"1","author":"Wong","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1157\/13101982_bib165","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0016-5085(76)80372-1","article-title":"Association of inflammatory bowel disease and large vascular lesions","volume":"71","author":"Yassinger","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib166","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ncpgasthep0190","article-title":"Therapy insight: Vascular complications in patients with inflammatory bowel disease","volume":"2","author":"Koutroubakis","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib167","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"Rothfuss","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1157\/13101982_bib168","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF01308436","article-title":"Gastrointestinal bleeding due to chronic portal vein thrombosis in ulcerative colitis","volume":"24","author":"Capron","year":"1979","journal-title":"Dig Dis Sci"},{"key":"10.1157\/13101982_bib169","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02050678","article-title":"Arterial thromboembolic complications of inflammatory bowel disease. Report of three cases","volume":"35","author":"Novotny","year":"1992","journal-title":"Dis Colon Rectum"},{"key":"10.1157\/13101982_bib170","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/j.1572-0241.2000.03193.x","article-title":"Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?","volume":"95","author":"Oldenburg","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib171","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10620-005-1588-y","article-title":"Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia","volume":"50","author":"Oldenburg","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1157\/13101982_bib172","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00365520410004622","article-title":"Massive haemorrhage induced by low molecular weight heparin in a patient with steroid refractory ulcerative colitis","volume":"39","author":"Kaya","year":"2004","journal-title":"Scand J Gastro enterol"},{"key":"10.1157\/13101982_bib173","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3748\/wjg.v12.i30.4794","article-title":"Conventional therapy for Crohn\u2019s disease","volume":"12","author":"Buning","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1157\/13101982_bib174","series-title":"Enfermedad inflamatoria intestinal","first-page":"327","article-title":"Situaciones cl\u00ednicas equ\u00edvocas en la enfermedad inflamatoria intestinal","author":"Cabre","year":"2002"},{"key":"10.1157\/13101982_bib175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.gtc.2004.02.002","article-title":"Treatment of inflammatory bowel disease with corticosteroids","volume":"33","author":"Katz","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1157\/13101982_bib176","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/gut.16.8.579","article-title":"Assessment of severity in colitis: a preliminary study","volume":"16","author":"Lennard-Jones","year":"1975","journal-title":"Gut"},{"key":"10.1157\/13101982_bib177","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0140-6736(78)91816-0","article-title":"Further experience in the treatment of se vere attacks of ulcerative colitis","volume":"2","author":"Truelove","year":"1978","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib178","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0016-5085(84)90409-8","article-title":"European Cooperative Crohn\u2019s Disease Study (ECCDS): results of drug treatment","volume":"86","author":"Malchow","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib179","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000200339","article-title":"Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment","volume":"46","author":"Oshitani","year":"1990","journal-title":"Digestion"},{"key":"10.1157\/13101982_bib180","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90002-I","article-title":"Clinical, biological, and endoscopic picture of attacks of Crohn\u2019s disease. Evolution on prednisolone. Groupe d\u2019Etude Therapeutique des Affections Inflammatoires Digestives","volume":"98","author":"Modigliani","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib181","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0016-5085(92)91725-J","article-title":"Endoscopic monitoring of Crohn\u2019s disease treatment: a prospective, randomized clinical trial. The Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires Digestives","volume":"102","author":"Landi","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib182","first-page":"852","article-title":"Predictors and the rate of medical treatment failure in ulcerative colitis","volume":"88","author":"Chakravarty","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib183","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","article-title":"Frequency of glucocorticoid resistance and dependency in Crohn\u2019s disease","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"key":"10.1157\/13101982_bib184","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJM199409293311304","article-title":"A comparison of budesonide with prednisolone for active Crohn\u2019s disease","volume":"331","author":"Rutgeerts","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1157\/13101982_bib185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004836-199506000-00004","article-title":"How effective is current medical therapy for severe ulcerative and Crohn\u2019s colitis? An analytic review of selected trials","volume":"20","author":"Kornbluth","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib186","first-page":"905","article-title":"Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn\u2019s disease. German\/Austrian Budesonide Study Group","volume":"8","author":"Gross","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib187","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00054725-199808000-00001","article-title":"Intravenous corticotrophin vs. hydrocortisone in the treatment of hospitalized patients with Crohn\u2019 s disease: a randomized double-blind study and follow-up","volume":"4","author":"Chun","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1157\/13101982_bib188","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib189","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2002.05596.x","article-title":"Corticosteroids in Crohn\u2019s disease","volume":"97","author":"Yang","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib190","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4321\/S1130-01082004000800003","article-title":"Response of first attack of inflammatory bowel disease requiring hospital admission to steroid therapy","volume":"96","author":"Abu-Suboh Abadia","year":"2004","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1157\/13101982_bib191","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2036.2006.02974.x","article-title":"The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort","volume":"24","author":"Ho","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib192","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bmj.1.5119.387","article-title":"Cortisone and corticotrophin in ulcerative colitis","volume":"25","author":"Truelove","year":"1959","journal-title":"BMJ"},{"key":"10.1157\/13101982_bib193","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(74)90552-2","article-title":"Intensive intravenous regimen for severe attacks of ulcerative colitis","volume":"1","author":"Truelove","year":"1974","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib194","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0140-6736(79)91907-X","article-title":"How district hospitals see acute colitis","volume":"1","author":"Buckell","year":"1979","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0016-5085(83)90323-2","article-title":"Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial","volume":"85","author":"Meyers","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib196","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0016-5085(85)90201-X","article-title":"Intensive intravenous treatment of ulcerative colitis","volume":"89","author":"Jarnerot","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib197","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gut.38.6.905","article-title":"Predicting outcome in severe ulcerative colitis","volume":"38","author":"Travis","year":"1996","journal-title":"Gut"},{"key":"10.1157\/13101982_bib198","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00042737-199810000-00003","article-title":"Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis","volume":"10","author":"Lindgren","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib199","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2036.2000.00705.x","article-title":"Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis","volume":"14","author":"Carbonnel","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib200","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1440-1746.2004.03486.x","article-title":"Severe ulcerative colitis: prospective study of parameters determining outcome","volume":"19","author":"Kumar","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib201","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dld.2003.04.001","article-title":"Outcome of a conservative approach in severe ulcerative colitis","volume":"36","author":"Daperno","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib202","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-2036.2004.01945.x","article-title":"Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery","volume":"19","author":"Ho","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib203","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.dld.2003.12.017","article-title":"Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment","volume":"36","author":"Benazzato","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib204","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s10620-006-9103-7","article-title":"Predictors of clinical response to systemic steroids in active ulcerative colitis","volume":"51","author":"Bernal","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1157\/13101982_bib205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00054725-200005000-00009","article-title":"Prediction of treatment refractoriness in ulcerative colitis and Crohn\u2019s disease: do we have reliable markers?","volume":"6","author":"Gelbmann","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1157\/13101982_bib206","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.dld.2004.03.002","article-title":"Predicting outcome in severe ulcerative colitis","volume":"36","author":"Travis","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib207","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004836-198702000-00013","article-title":"Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial","volume":"9","author":"Meyers","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib208","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmj.2.5302.441","article-title":"Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone","volume":"5302","author":"Baron","year":"1962","journal-title":"BMJ"},{"key":"10.1157\/13101982_bib209","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/j.amjgastroenterol.2003.10.007","article-title":"Evidence-based treatment algorithm for mild to moderate Crohn\u2019s disease","volume":"98","author":"Sandborn","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib210","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.gastro.2006.01.047","article-title":"American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib211","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/j.gastro.2006.01.048","article-title":"American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib212","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004836-199002000-00011","article-title":"High-dose methylprednisolone in the treatment of active ulcerative colitis","volume":"12","author":"Rosenberg","year":"1990","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib213","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/gut.24.3.182","article-title":"Absorption of prednisolone in patients with Crohn\u2019s disease","volume":"24","author":"Shaffer","year":"1983","journal-title":"Gut"},{"key":"10.1157\/13101982_bib214","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00004836-198604000-00010","article-title":"Use of an intravenous steroid regimen in the treatment of acute Crohn\u2019s disease","volume":"8","author":"Shepherd","year":"1986","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib215","series-title":"Enfermedad inflamatoria intestinal","first-page":"315","article-title":"Corticorresistencia y corticodependencia en la enfermedad inflamatoria intestinal","author":"Esteve","year":"2002"},{"key":"10.1157\/13101982_bib216","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1157\/13101982_bib217","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0210-5705(05)71523-5","article-title":"Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review","volume":"28","author":"Garc\u00eda-L\u00f3pez","year":"2005","journal-title":"Gastroenterol Hepatol"},{"issue":"Suppl 3","key":"10.1157\/13101982_bib218","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2036.2006.03064.x","article-title":"Review article: saving the colon in severe colitis: the case for medical therapy","volume":"24","author":"Travis","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib219","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gut.27.10.1210","article-title":"Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis","volume":"27","author":"Chapman","year":"1986","journal-title":"Gut"},{"key":"10.1157\/13101982_bib220","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0016-5085(85)90226-4","article-title":"Systemic corticosteroid therapy of ulcerative colitis","volume":"89","author":"Meyers","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib221","first-page":"732","article-title":"Prolonged medical therapy for severe pediatric ulcerative colitis","volume":"90","author":"Gold","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib222","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.dld.2003.10.002","article-title":"Conservative approach to severe ulcerative colitis","volume":"36","author":"Fedorak","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1157\/13101982_bib223","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0016-5085(93)90738-X","article-title":"Clinical and colonoscopic surveillance in ulcerative colitis: are we saving colons or saving lives?","volume":"105","author":"Sachar","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib224","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1046\/j.1365-2036.2001.01102.x","article-title":"Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine","volume":"15","author":"Nielsen","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2005.02520.x","article-title":"Review article: practical management of inflammatory bowel disease patients taking immunomodulators","volume":"22","author":"Siegel","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib226","first-page":"423","article-title":"A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate","volume":"91","author":"Sandborn","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib227","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/gut.48.5.591","article-title":"Rational dosing of azathioprine and 6-mercaptopurine","volume":"48","author":"Sandborn","year":"2001","journal-title":"Gut"},{"key":"10.1157\/13101982_bib228","article-title":"Azathioprine or 6-mercaptopurine for inducing remission of Crohn\u2019s disease","author":"Sandborn","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1157\/13101982_bib229","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.gtc.2004.02.004","article-title":"Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine","volume":"33","author":"Su","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1157\/13101982_bib230","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","article-title":"Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety","volume":"2","author":"Dubinsky","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib231","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/0016-5085(95)90747-5","article-title":"An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn\u2019s disease","volume":"109","author":"Sandborn","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib232","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2036.1999.00559.x","article-title":"Low-dose intravenous azathioprine may be effective in the management of acute fulminant colitis complicating inflammatory bowel disease","volume":"13","author":"Casson","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib233","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0016-5085(99)70445-2","article-title":"Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn\u2019s disease. North American Azathioprine Study Group","volume":"117","author":"Sandborn","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib234","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00365529950173096","article-title":"Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study","volume":"34","author":"Rasmussen","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1157\/13101982_bib235","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2036.2004.02197.x","article-title":"Increased incidence of azathioprine-induced pancreatitis in Crohn\u2019s disease compared with other diseases","volume":"20","author":"Weersma","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib236","first-page":"1161","article-title":"Corticosteroid-induced pancreatitis: a case report demonstrating recurrence with rechallenge","volume":"83","author":"Levine","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib237","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.1996.tb00174.x","article-title":"Review article: drug-induced pancreatitis","volume":"10","author":"McArthur","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib238","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00005176-199707000-00020","article-title":"Pancreatitis in patients with inflammatory bowel disease","volume":"25","author":"Keljo","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1157\/13101982_bib239","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1572-0241.2003.07459.x","article-title":"Risk of acute pancreatitis in users of azathioprine: a population-based case-control study","volume":"98","author":"Floyd","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib240","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1572-0241.2004.04123.x","article-title":"Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study","volume":"99","author":"Munk","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib241","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0210-5705(02)70275-6","article-title":"Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease","volume":"25","author":"Gisbert","year":"2002","journal-title":"Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib242","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0016-5085(86)90703-1","article-title":"Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease","volume":"91","author":"Haber","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib243","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0016-5085(91)90457-V","article-title":"Use of azathioprine or 6-mercaptopurine in the treatment of Crohn\u2019s disease","volume":"101","author":"O\u2019Brien","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib244","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00004836-200309000-00006","article-title":"Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn\u2019s disease and ulcerative colitis","volume":"37","author":"Warman","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00042737-200402000-00014","article-title":"Side effects of azathioprine in patients with Crohn\u2019s disease","volume":"16","author":"De Jong","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib246","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00002018-200023050-00006","article-title":"Comparative tolerability of treatments for inflammatory bowel disease","volume":"23","author":"Stein","year":"2000","journal-title":"Drug Saf"},{"key":"10.1157\/13101982_bib247","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00004836-198912000-00017","article-title":"Rapid development of pancreatitis following reuse of 6-mercaptopurine","volume":"11","author":"Cappell","year":"1989","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib248","series-title":"Ciclosporina y otros inmunomoduladores. Gastroenterolog\u00eda y Hepatolog\u00eda Continuada","author":"Gonz\u00e1lez-Lama","year":"2006"},{"key":"10.1157\/13101982_bib249","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004277.pub2","article-title":"Cyclosporine A for induction of remission in severe ulcerative colitis","author":"Shibolet","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1157\/13101982_bib250","first-page":"1424","article-title":"Cyclosporin for severe ulcerative colitis: a user\u2019s guide","volume":"92","author":"Kornbluth","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib251","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0016-5085(03)01214-9","article-title":"Randomized, double-blind comparison of 4mg\/kg versus 2mg\/kg intravenous cyclosporine in severe ulcerative colitis","volume":"125","author":"Van Assche","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib252","first-page":"2498","article-title":"Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis","volume":"91","author":"Fern\u00e1ndez-Banares","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib253","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1046\/j.1365-2036.2002.01385.x","article-title":"Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis","volume":"16","author":"Dom\u00e9nech","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib254","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2036.2006.02779.x","article-title":"Is oral ciclosporin necessary to switch from i.v. to thiopurines?","volume":"23","author":"Dom\u00e9nech","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib255","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2165\/00003495-200464160-00004","article-title":"Managing immunogenic responses to infliximab: treatment implications for patients with Crohn\u2019s disease","volume":"64","author":"Han","year":"2004","journal-title":"Drugs"},{"key":"10.1157\/13101982_bib256","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1111\/j.1572-0241.2000.03363.x","article-title":"Infliximab in Crohn\u2019s disease: first anniversary clinical experience","volume":"95","author":"Cohen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib257","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/j.1572-0241.2000.03366.x","article-title":"Clinical experience with infliximab therapy in 100 patients with Crohn\u2019s disease","volume":"95","author":"Farrell","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib258","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib259","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","article-title":"The incidence and management of infusion reactions to infliximab: a large center experience","volume":"98","author":"Cheifetz","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib260","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","article-title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn\u2019s disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib261","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn\u2019s disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib262","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn\u2019s disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib263","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0039-6060(03)00298-8","article-title":"Multivariate analysis suggests improved perioperative outcome in Crohn\u2019s disease patients receiving immunomodulator therapy after segmental resection and\/or strictureplasty","volume":"134","author":"Tay","year":"2003","journal-title":"Surgery"},{"key":"10.1157\/13101982_bib264","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/bjs.5375","article-title":"Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators","volume":"93","author":"Subramanian","year":"2006","journal-title":"Br J Surg"},{"key":"10.1157\/13101982_bib265","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1572-0241.2004.04148.x","article-title":"Early postoperative complications are not increased in patients with Crohn\u2019s disease treated perioperatively with infliximab or immunosuppressive therapy","volume":"99","author":"Colombel","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib266","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2004.01904.x","article-title":"The risk of post-operative complications associated with infliximab therapy for Crohn\u2019s disease: a controlled cohort study","volume":"19","author":"Marchal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib267","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1365-2036.2006.02878.x","article-title":"Maintenance infliximab does not result in increased abscess development in fistulizing Crohn\u2019s disease: results from the ACCENT II study","volume":"23","author":"Sands","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib268","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0016-5085(02)80138-X","article-title":"The NOD2 gene and Crohn\u2019s disease: another triumph for molecular genetics","volume":"122","author":"Judge","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib269","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000083870","article-title":"Extraintestinal manifestations of Crohn\u2019s disease","volume":"71","author":"Juillerat","year":"2005","journal-title":"Digesti\u00f3n"},{"key":"10.1157\/13101982_bib270","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00004836-200607000-00003","article-title":"Extraintestinal manifestations of inflammatory bowel diseases","volume":"40","author":"Kethu","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13101982_bib271","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/pgmj.2004.031633","article-title":"Important cutaneous manifestations of inflammatory bowel disease","volume":"81","author":"Trost","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1157\/13101982_bib272","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bmj.333.7560.181","article-title":"Diagnosis and treatment of pyoderma gangrenosum","volume":"333","author":"Brooklyn","year":"2006","journal-title":"Bmj"},{"key":"10.1157\/13101982_bib273","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","article-title":"Pyoderma gangrenosum","volume":"351","author":"Callen","year":"1998","journal-title":"Lancet"},{"key":"10.1157\/13101982_bib274","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/bmj.316.7124.52","article-title":"Early diagnosis of pyoderma gangrenosum is important to prevent disfigurement","volume":"316","author":"Harris","year":"1998","journal-title":"Bmj"},{"key":"10.1157\/13101982_bib275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1157\/13101982_bib276","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ncpgasthep0339","article-title":"Therapy Insight: pyoderma gangrenosum-old disease, new management","volume":"2","author":"Campbell","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1157\/13101982_bib277","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: special situations","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"},{"key":"10.1157\/13101982_bib278","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-200102000-00001","article-title":"Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease","volume":"7","author":"Friedman","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1157\/13101982_bib279","first-page":"930","article-title":"Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody","volume":"137","author":"Tan","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1157\/13101982_bib280","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/003655202320378338","article-title":"Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab","volume":"37","author":"Ljung","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1157\/13101982_bib281","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/00042737-200208000-00021","article-title":"Infliximab induces remission of pyoderma gangrenosum","volume":"14","author":"Romero-G\u00f3mez","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib282","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000065860","article-title":"Corticosteroid-resistant pyoderma gangrenosum associated with Crohn\u2019s disease: rapid cure with infliximab","volume":"205","author":"Grange","year":"2002","journal-title":"Dermatology"},{"key":"10.1157\/13101982_bib283","first-page":"258","article-title":"Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn\u2019s disease","volume":"13","author":"Zaccagna","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1157\/13101982_bib284","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib285","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4321\/S1130-01082004000600008","article-title":"Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab","volume":"96","author":"L\u00f3pez San Roman","year":"2004","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1157\/13101982_bib286","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2133.2005.06812.x","article-title":"Severe recalcitrant pyoderma gangrenosum treated with infliximab","volume":"153","author":"Kaur","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1157\/13101982_bib287","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"10.1157\/13101982_bib288","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2036.2005.02680.x","article-title":"Review article: how and when to use ciclosporin in ulcerative colitis","volume":"22","author":"Durai","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib289","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2165\/00003495-200565150-00014","article-title":"Infliximab: a review of its use in Crohn\u2019s disease and rheumatoid arthritis","volume":"65","author":"Siddiqui","year":"2005","journal-title":"Drugs"},{"key":"10.1157\/13101982_bib290","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2165\/00003495-200565160-00002","article-title":"Biologic therapy for inflammatory bowel disease","volume":"65","author":"Ardizzone","year":"2005","journal-title":"Drugs"},{"key":"10.1157\/13101982_bib291","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2036.2006.02786.x","article-title":"Review article: infliximab therapy for inflammatory bowel disease: seven years on","volume":"23","author":"Rutgeerts","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13101982_bib292","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2004.02.070","article-title":"Optimizing anti-TNF treatment in inflammatory bowel disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1157\/13101982_bib293","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00054725-200403000-00012","article-title":"Ocular manifestations of inflammatory bowel disease","volume":"10","author":"Mintz","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1157\/13101982_bib294","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archopht.1997.01100150063010","article-title":"Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy","volume":"115","author":"Lyons","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1157\/13101982_bib295","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9394(14)76575-4","article-title":"Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease","volume":"118","author":"Soukiasian","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1157\/13101982_bib296","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1572-0241.2002.05514.x","article-title":"Treatment of acute uveitis associated with Crohn\u2019s disease and sacroileitis with infliximab","volume":"97","author":"Fries","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13101982_bib297","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":"Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1157\/13101982_bib298","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cgh.2006.05.011","article-title":"Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn\u2019s disease","volume":"4","author":"Markowitz","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1157\/13101982_bib299","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cgh.2006.04.008","article-title":"The natural history of corticosteroid therapy for ulcerative colitis in children","volume":"4","author":"Hyams","year":"2006","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570507723105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570507723105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T12:23:44Z","timestamp":1628943824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570507723105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":299,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0210570507723105"],"URL":"https:\/\/doi.org\/10.1157\/13101982","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}